Silencing of Kv4.1 potassium channels inhibits cell proliferation of tumorigenic human mammary epithelial cells

Biochemical and Biophysical Research Communications

Volumn 384, Issue 2, 2009, Pages 180-186

  Jang, Soo Hwa ^a   Choi, Changsun ^b   Hong, Seong Geun ^c   Yarishkin, Oleg V ^c   Bae, Young Min ^d   Kim, Jae Gon ^d   O'Grady, Scott M ^e   Yoon, Kyong Ah ^f   Kang, Kyung Sun ^a   Ryu, Pan Dong ^a   Lee, So Yeong ^a  

^a Seoul National University   (South Korea)

^b Chung Ang University   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

^d Konkuk University School of Medicine   (South Korea)

^e UNIVERSITY OF MINNESOTA   (United States)

^f National Cancer Center   (South Korea)

Author keywords

Breast cancer; Cell growth; Voltage gated K+ channels

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER INHIBITION; CANCER TISSUE; CARCINOGENICITY; CELL ISOLATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE SILENCING; HUMANS; RNA, SMALL INTERFERING; SHAL POTASSIUM CHANNELS;

EID: 65549137217     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.108     Document Type: Article

References (31)

1. Yu F.H., and Catterall W.A. The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci. STKE 2004 (2004) re15
2. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stuhmer W., and Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationship of voltage-gated potassium channels. Pharmacol. Rev. 57 (2005) 473-508
3. DeCoursey T.E., Chandy K.G., Gupta S., and Cahalan M.D. Voltage-dependent ion channels in T-lymphocytes. J. Neuroimmunol. 10 (1985) 71-95
4. O'Grady S.M., and Lee S.Y. Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int. J. Biochem. Cell Biol. 37 (2005) 1578-1594
5. Abdul M., Santo A., and Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res. 23 (2003) 3347-3351
6. Ouadid-Ahidouch H., Chaussade F., Roudbaraki M., Slomianny C., Dewailly E., Delcourt P., and Prevarskaya N. KV1.1 K(+) channels identification in human breast carcinoma cells: involvement in cell proliferation. Biochem. Biophys. Res. Commun. 278 (2000) 272-277
7. + channels in normal and cancerous human breast. Histol. Histopathol. 23 (2008) 965-972
8. Abdul M., and Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 9 (2002) 961-964
9. 2+ influx in carcinoma cells of colon cancer. Life Sci. 65 (1999) 55-62
10. Lan M., Shi Y., Han Z., Hao Z., Pan Y., Liu N., Guo C., Hong L., Wang J., Qiao T., and Fan D. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol. Ther. 4 (2005) 1342-1347
11. Nilius B., and Wohlrab W. Potassium channels and regulation of proliferation of human melanoma cells. J. Physiol. 445 (1992) 537-548
12. Abdul M., and Hoosein N. Voltage-gated sodium ion channels in prostate cancer: expression and activity. Anticancer Res. 22 (2002) 1727-1730
13. Kang K.S., Sun W., Nomata K., Morita I., Cruz A., Liu C.J., Trosko J.E., and Chang C.C. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinog. 21 (1998) 225-233
14. Kao C.Y., Nomata K., Oakley C.S., Welsch C.W., and Chang C.C. Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis 16 (1995) 531-538
15. Woelfle U., Sauter G., Santjer S., Brakenhoff R., and Pantel K. Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer. Clin. Cancer Res. 8 (2004) 2670-2674
16. Birnbaum S.G., Varga A.W., Yuan L.L., Anderson A.E., Sweatt J.D., and Schrader L.A. Structure and function of Kv4-family transient potassium channels. Physiol. Rev. 84 (2004) 803-833
17. + channels that are located in apical membrane. Am. J. Physiol. Cell Physiol. 284 (2003) C1614-C1624
18. An W.F., Bowlby M.R., Betty M., Cao J., Ling H.P., Mendoza G., Hinson J.W., Mattsson K.I., Strassle B.W., Trimmer J.S., and Rhodes K.J. Modulation of A-type potassium channels by a family of calcium sensors. Nature 403 (2000) 553-556
19. 2-terminally spliced modulator of Kv4 channels. Am. J. Physiol. Cell Physiol. 285 (2003) C161-C170
20. Rhodes K.J., Carroll K.I., Sung M.A., Doliveira L.C., Monaghan M.M., Burke S.L., Strassle B.W., Buchwalder L., Menegola M., Cao J., An W.F., and Trimmer J.S. KChIPs and Kv4 alpha subunits as integral components of A-type potassium channels in mammalian brain. J. Neurosci. 24 (2004) 7903-7915
21. Liu Z., Xiao X.J., Fan F.Y., Sun Y.M., Li Y.M., and Yang F.J. Discovery of a new splicing type of KCHIP1 gene. Ai Zheng 24 (2005) 755-756
22. Czarnecki A., Dufy-Barbe L., Huet S., Odessa M.F., and Bresson-Bepoldin L. Potassium channel expression level is dependent on the proliferation state in the GH3 pituitary cell line. Am. J. Physiol. Cell Physiol. 284 (2003) C1054-C1064
23. Andersson I., and Ryden S. Early detection and prevention: benefits, costs and limitations of screening. In: Tobias J.S., Houghton J., and Henderson I.C. (Eds). Breast Cancer (2001), Arnold, London 105-117
24. Diss J.K., Stewart D., Pani F., Foster C.S., Walker M.M., Patel A., and Djamgoz M.B. A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis. 8 (2005) 266-273
25. 2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene 22 (2003) 7858-7861
26. Gurney A.M., and Hunter E. The use of small interfering RNA to elucidate the activity and function of ion channel genes in an intact tissue. J. Pharmacol. Toxicol. Methods 51 (2005) 253-262
27. Takeshita F., and Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci. 97 (2006) 689-696
28. Chen G., Gharib T.G., Huang C.C., Taylor J.M., Misek D.E., Kardia S.L., Giordano T.J., Iannettoni M.D., Orringer M.B., Hanash S.M., and Beer D.G. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell Proteomics 1 (2002) 304-313
29. Strobl J.S., Wonderlin W.F., and Flynn D.C. Mitogenic signal transduction in human breast cancer cells. Gen. Pharmacol. 26 (1995) 1643-1649
30. Kunzelmann K. Ion channels and cancer. J. Membr. Biol. 205 (2005) 159-173
31. Wonderlin W.F., Woodfork K.A., and Strobl J.S. Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J. Cell Physiol. 165 (1995) 177-185